GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
Y

Yonghe Medical Group Co 2279.HK · HKD

Health Care · HKEX · 🇭🇰 Hong Kong

Compare

2.17

+5.85%

Close of 9 Nov 2026, in HKD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in CNY, from our data supplier.

FY2025

Revenue

CN¥1.81bn

FY2018FY2025

Net income

CN¥73.7m

FY2018FY2025

Free cash flow

CN¥476.6m

FY2018FY2025

Shareholders' equity

CN¥788.1m

FY2018FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
RevenueCN¥1.81bnCN¥1.53bnCN¥1.51bnCN¥1.20bnCN¥2.17bnCN¥1.64bnCN¥1.22bnCN¥934.3m
Research and developmentCN¥19.3mCN¥18.0mCN¥24.8mCN¥15.7mCN¥14.2mCN¥11.8mCN¥8.9mCN¥7.8m
Operating incomeCN¥120.0m−CN¥139.0m−CN¥451.0m−CN¥137.1mCN¥249.2mCN¥266.3mCN¥98.0mCN¥129.0m
Net incomeCN¥73.7m−CN¥192.0m−CN¥463.5m−CN¥72.8mCN¥120.2mCN¥163.3mCN¥35.6mCN¥53.5m
Diluted earnings per share0.15-0.37-0.88-0.140.230.310.070.11

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Total assetsCN¥1.70bnCN¥1.73bnCN¥2.44bnCN¥2.93bnCN¥3.20bnCN¥1.59bnCN¥931.2mCN¥734.4m
Cash and short-term investments——CN¥603.2mCN¥978.0mCN¥1.57bnCN¥292.9mCN¥89.8mCN¥68.5m
Total liabilitiesCN¥914.5mCN¥1.01bnCN¥1.50bnCN¥1.35bnCN¥1.50bnCN¥1.19bnCN¥692.1mCN¥530.9m
Debt——CN¥925.5mCN¥845.0mCN¥836.5mCN¥708.7mCN¥456.0mCN¥324.9m
Shareholders' equityCN¥788.1mCN¥714.3mCN¥942.6mCN¥1.59bnCN¥1.70bnCN¥406.1mCN¥239.1mCN¥203.5m
Shares outstanding500m525m527m527m527m520m500m500m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Cash from operationsCN¥495.5mCN¥228.6m−CN¥17.2m−CN¥108.6mCN¥437.3mCN¥501.6mCN¥182.5mCN¥194.6m
Capital spending−CN¥18.9m−CN¥53.8m−CN¥171.3m−CN¥243.5m−CN¥181.6m−CN¥142.2m−CN¥105.8m−CN¥135.4m
Free cash flowCN¥476.6mCN¥174.9m−CN¥188.5m−CN¥352.1mCN¥255.7mCN¥359.4mCN¥76.7mCN¥59.1m
Dividends paid———−CN¥43.2m−CN¥69.8m−CN¥69.8m−CN¥69.8m−CN¥69.8m

Latest quarters

By quarter end

Dec 2025Jun 2025Dec 2024Jun 2024Dec 2023Jun 2023Dec 2022Jun 2022
RevenueCN¥946.8mCN¥861.5mCN¥767.0mCN¥763.6mCN¥805.3mCN¥827.8mCN¥664.7mCN¥748.1m
Operating incomeCN¥75.3mCN¥44.7m−CN¥28.2m−CN¥110.8m−CN¥260.1m−CN¥225.1m−CN¥138.2m−CN¥23.4m
Net incomeCN¥45.8mCN¥27.9m−CN¥74.4m−CN¥117.5m−CN¥271.6m−CN¥226.2m−CN¥103.5mCN¥17.6m
Diluted earnings per share0.090.06-0.14-0.22-0.52-0.43-0.200.03
Cash from operations—CN¥208.0mCN¥193.0mCN¥62.0m−CN¥17.0m−CN¥12.0m−CN¥12.0m−CN¥40.0m
Capital spending—−CN¥8.0m−CN¥45.0m−CN¥15.0m−CN¥171.0m−CN¥53.0m−CN¥53.0m−CN¥49.0m
Free cash flow—CN¥200.0mCN¥148.0mCN¥47.0m−CN¥188.0m−CN¥65.0m−CN¥65.0m−CN¥89.0m
Total assetsCN¥1.70bnCN¥1.61bnCN¥1.73bnCN¥1.77bnCN¥2.07bnCN¥2.73bnCN¥2.49bnCN¥3.13bn
Cash and short-term investments——CN¥487.8mCN¥452.8mCN¥511.7mCN¥632.7mCN¥829.6mCN¥1.40bn
Debt——CN¥516.6mCN¥641.6mCN¥785.0mCN¥891.3mCN¥716.8mCN¥864.7m
Shareholders' equityCN¥788.1mCN¥742.2mCN¥714.3mCN¥680.4mCN¥799.5mCN¥1.27bnCN¥1.34bnCN¥1.81bn

Growth per year

Compound annual rate

3 years5 years10 years
Revenue16.6%2.6%—
Operating income—-14.7%—
Net income—-14.7%—

Average margins

Over each period

1 year3 years5 years10 years
Operating margin-0.6%-10.0%-0.9%—
Net margin-3.5%-10.8%-3.8%—

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021
Price to earnings9.6-2.1-2.5-75.060.7
Price to sales0.40.30.84.93.5

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years. Last went ex-dividend on 30 Jun 2022.

FY2022
Paid in the year0.093

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.